Analysis of factors associated with development of Bacille Calmette–Guérin inoculation site change in patients with Kawasaki disease

Tooru Araki, Aya Kodera, Kunimi Kitada, Michimasa Fujiwara, Michiko Muraoka, Yoshiko Abe, Masanori Ikeda, Hirokazu Tsukahara

Research output: Contribution to journalArticle

Abstract

Objective: The present study was performed to identify factors associated with a Bacille Calmette–Guérin (BCG) inoculation site change in patients with Kawasaki disease (KD). Methods: Among patients who had received BCG vaccination and treatment for KD at our hospital from 2005 through 2016, 177 patients born in 2005 through 2016 were enrolled. The patients were divided into those with (n = 83, change group) and without (n = 94, no-change group) a BCG site change, and the patient demographics, clinical severity, blood examination results, and echocardiographic findings were compared between the two groups. Results: The change group was younger at onset and had a shorter interval from vaccination to onset. A BCG site change was observed in patients who developed the onset of KD symptoms from 31 to 806 days after BCG vaccination. Multivariate analysis showed that the interval from vaccination was closely and positively associated with the BCG site change (hazard ratio = 0.995, 95% confidence interval = 0.993–0.997). Conclusion: A BCG site change in patients with KD is most closely associated with the interval from BCG vaccination to onset.

Original languageEnglish
Pages (from-to)1640-1648
Number of pages9
JournalJournal of International Medical Research
Volume46
Issue number4
DOIs
Publication statusPublished - Apr 1 2018

Fingerprint

Mucocutaneous Lymph Node Syndrome
Statistical Factor Analysis
Vaccination
Hazards
Blood
Multivariate Analysis
Demography
Confidence Intervals

Keywords

  • Bacille Calmette–Guérin
  • infant
  • inoculation site change
  • Japan
  • Kawasaki disease
  • risk factors

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology
  • Biochemistry, medical

Cite this

Analysis of factors associated with development of Bacille Calmette–Guérin inoculation site change in patients with Kawasaki disease. / Araki, Tooru; Kodera, Aya; Kitada, Kunimi; Fujiwara, Michimasa; Muraoka, Michiko; Abe, Yoshiko; Ikeda, Masanori; Tsukahara, Hirokazu.

In: Journal of International Medical Research, Vol. 46, No. 4, 01.04.2018, p. 1640-1648.

Research output: Contribution to journalArticle

Araki, Tooru ; Kodera, Aya ; Kitada, Kunimi ; Fujiwara, Michimasa ; Muraoka, Michiko ; Abe, Yoshiko ; Ikeda, Masanori ; Tsukahara, Hirokazu. / Analysis of factors associated with development of Bacille Calmette–Guérin inoculation site change in patients with Kawasaki disease. In: Journal of International Medical Research. 2018 ; Vol. 46, No. 4. pp. 1640-1648.
@article{9161493995514ae29e588a850d822a2d,
title = "Analysis of factors associated with development of Bacille Calmette–Gu{\'e}rin inoculation site change in patients with Kawasaki disease",
abstract = "Objective: The present study was performed to identify factors associated with a Bacille Calmette–Gu{\'e}rin (BCG) inoculation site change in patients with Kawasaki disease (KD). Methods: Among patients who had received BCG vaccination and treatment for KD at our hospital from 2005 through 2016, 177 patients born in 2005 through 2016 were enrolled. The patients were divided into those with (n = 83, change group) and without (n = 94, no-change group) a BCG site change, and the patient demographics, clinical severity, blood examination results, and echocardiographic findings were compared between the two groups. Results: The change group was younger at onset and had a shorter interval from vaccination to onset. A BCG site change was observed in patients who developed the onset of KD symptoms from 31 to 806 days after BCG vaccination. Multivariate analysis showed that the interval from vaccination was closely and positively associated with the BCG site change (hazard ratio = 0.995, 95{\%} confidence interval = 0.993–0.997). Conclusion: A BCG site change in patients with KD is most closely associated with the interval from BCG vaccination to onset.",
keywords = "Bacille Calmette–Gu{\'e}rin, infant, inoculation site change, Japan, Kawasaki disease, risk factors",
author = "Tooru Araki and Aya Kodera and Kunimi Kitada and Michimasa Fujiwara and Michiko Muraoka and Yoshiko Abe and Masanori Ikeda and Hirokazu Tsukahara",
year = "2018",
month = "4",
day = "1",
doi = "10.1177/0300060518760462",
language = "English",
volume = "46",
pages = "1640--1648",
journal = "Journal of International Medical Research",
issn = "0300-0605",
publisher = "Field House Publishing LLP",
number = "4",

}

TY - JOUR

T1 - Analysis of factors associated with development of Bacille Calmette–Guérin inoculation site change in patients with Kawasaki disease

AU - Araki, Tooru

AU - Kodera, Aya

AU - Kitada, Kunimi

AU - Fujiwara, Michimasa

AU - Muraoka, Michiko

AU - Abe, Yoshiko

AU - Ikeda, Masanori

AU - Tsukahara, Hirokazu

PY - 2018/4/1

Y1 - 2018/4/1

N2 - Objective: The present study was performed to identify factors associated with a Bacille Calmette–Guérin (BCG) inoculation site change in patients with Kawasaki disease (KD). Methods: Among patients who had received BCG vaccination and treatment for KD at our hospital from 2005 through 2016, 177 patients born in 2005 through 2016 were enrolled. The patients were divided into those with (n = 83, change group) and without (n = 94, no-change group) a BCG site change, and the patient demographics, clinical severity, blood examination results, and echocardiographic findings were compared between the two groups. Results: The change group was younger at onset and had a shorter interval from vaccination to onset. A BCG site change was observed in patients who developed the onset of KD symptoms from 31 to 806 days after BCG vaccination. Multivariate analysis showed that the interval from vaccination was closely and positively associated with the BCG site change (hazard ratio = 0.995, 95% confidence interval = 0.993–0.997). Conclusion: A BCG site change in patients with KD is most closely associated with the interval from BCG vaccination to onset.

AB - Objective: The present study was performed to identify factors associated with a Bacille Calmette–Guérin (BCG) inoculation site change in patients with Kawasaki disease (KD). Methods: Among patients who had received BCG vaccination and treatment for KD at our hospital from 2005 through 2016, 177 patients born in 2005 through 2016 were enrolled. The patients were divided into those with (n = 83, change group) and without (n = 94, no-change group) a BCG site change, and the patient demographics, clinical severity, blood examination results, and echocardiographic findings were compared between the two groups. Results: The change group was younger at onset and had a shorter interval from vaccination to onset. A BCG site change was observed in patients who developed the onset of KD symptoms from 31 to 806 days after BCG vaccination. Multivariate analysis showed that the interval from vaccination was closely and positively associated with the BCG site change (hazard ratio = 0.995, 95% confidence interval = 0.993–0.997). Conclusion: A BCG site change in patients with KD is most closely associated with the interval from BCG vaccination to onset.

KW - Bacille Calmette–Guérin

KW - infant

KW - inoculation site change

KW - Japan

KW - Kawasaki disease

KW - risk factors

UR - http://www.scopus.com/inward/record.url?scp=85044827516&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044827516&partnerID=8YFLogxK

U2 - 10.1177/0300060518760462

DO - 10.1177/0300060518760462

M3 - Article

VL - 46

SP - 1640

EP - 1648

JO - Journal of International Medical Research

JF - Journal of International Medical Research

SN - 0300-0605

IS - 4

ER -